Switch to: References

Add citations

You must login to add citations.
  1. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.Teresa Leonardo Alves, Joel Lexchin & Barbara Mintzes - 2019 - Science and Engineering Ethics 25 (4):1167-1192.
    Many factors contribute to the inappropriate use of medicines, including not only a lack of information but also inaccurate and misleading promotional information. This review examines how the promotion of pharmaceuticals directly affects the prescribing and use of medicines. We define promotion broadly as all actions taken directly by pharmaceutical companies with the aim of enhancing product sales. We look in greater detail at promotion techniques aimed at prescribers, such as sales representatives, pharmaceutical advertisements in medical journals and use of (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations  
  • Direct-to-Consumer Advertising of Pharmaceuticals as a Matter of Corporate Social Responsibility?Pepijn K. C. van de Pol & Frank G. A. de Bakker - 2010 - Journal of Business Ethics 94 (2):211-224.
    Direct-to-consumer advertising (DTCA) of prescription drugs has been a heavily contested issue over the past decade, touching on several issues of responsibility facing the pharmaceutical industry. Much research has been conducted on DTCA, but hardly any studies have discussed this topic from a corporate social responsibility (CSR) perspective. In this article, we use several elements of CSR, emphasising consumer autonomy and safety, to analyse differences in DTCA practices within two different policy contexts, the United States of America and the European (...)
    Download  
     
    Export citation  
     
    Bookmark   3 citations